Related Experiment Video
Updated: Jul 16, 2026
09:31
Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Published on: March 22, 2016
In vitro analysis of transformation potential associated with retroviral vector insertions.
S K Powell1, M Kaloss, I Burimski
1Genetic Therapy, Inc., a Novartis Company, Gaithersburg, MD 20878, USA.
Human Gene Therapy
|September 25, 1999
Summary
Replication-defective retroviral vectors can cause genetic changes. This study found that the GlnBgSvNa retroviral vector did not induce cellular transformation in BALB/c-3T3 cells, setting a new safety benchmark.
Area of Science:
- Molecular Biology
- Gene Therapy
- Cancer Research
Background:
- Replication-defective retroviral vectors are used for gene therapy, enabling long-term gene expression.
- However, random insertions into the host genome can lead to insertional mutagenesis.
- Quantifying the risk of cellular transformation from these insertions is crucial for gene therapy safety.
Purpose of the Study:
- To assess the potential of the GlnBgSvNa retroviral vector to induce cellular transformation.
- To determine the transformation frequency in BALB/c-3T3 cells transduced with the GlnBgSvNa vector.
- To establish an upper limit for the rate of transformation induced by retroviral vectors.
Main Methods:
- Utilized the BALB/c-3T3 in vitro transformation assay.
- Transduced BALB/c-3T3 cells with the replication-defective GlnBgSvNa retroviral vector.
- Quantified transformation frequency in vector-transduced cells with integrated provirus.
Main Results:
- No significant difference in transformation frequency was observed between vector-transduced BALB/c-3T3 cells and untreated control cells.
- The GlnBgSvNa vector demonstrated a non-transforming phenotype in the assay.
- The transformation rate induced by GlnBgSvNa insertions was found to be less than 1.1 x 10(-5).
Conclusions:
- The GlnBgSvNa retroviral vector is non-transforming in the BALB/c-3T3 in vitro assay.
- This study provides the first defined upper limit for retroviral vector-induced cellular transformation rates.
- These findings contribute to the safety assessment of retroviral vectors in gene therapy applications.
Related Concept Videos
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...